IBDEI0B7 ; ; 19-NOV-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,4755,1,4,0)
 ;;=4^E11.65
 ;;^UTILITY(U,$J,358.3,4755,2)
 ;;=^5002663
 ;;^UTILITY(U,$J,358.3,4756,0)
 ;;=E11.618^^37^317^2
 ;;^UTILITY(U,$J,358.3,4756,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4756,1,3,0)
 ;;=3^Diabetes Type 2 w/ Diabetic Arthropathy
 ;;^UTILITY(U,$J,358.3,4756,1,4,0)
 ;;=4^E11.618
 ;;^UTILITY(U,$J,358.3,4756,2)
 ;;=^5002654
 ;;^UTILITY(U,$J,358.3,4757,0)
 ;;=E11.620^^37^317^3
 ;;^UTILITY(U,$J,358.3,4757,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4757,1,3,0)
 ;;=3^Diabetes Type 2 w/ Diabetic Dermatitis
 ;;^UTILITY(U,$J,358.3,4757,1,4,0)
 ;;=4^E11.620
 ;;^UTILITY(U,$J,358.3,4757,2)
 ;;=^5002655
 ;;^UTILITY(U,$J,358.3,4758,0)
 ;;=E11.621^^37^317^4
 ;;^UTILITY(U,$J,358.3,4758,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4758,1,3,0)
 ;;=3^Diabetes Type 2 w/ Foot Ulcer
 ;;^UTILITY(U,$J,358.3,4758,1,4,0)
 ;;=4^E11.621
 ;;^UTILITY(U,$J,358.3,4758,2)
 ;;=^5002656
 ;;^UTILITY(U,$J,358.3,4759,0)
 ;;=E11.622^^37^317^11
 ;;^UTILITY(U,$J,358.3,4759,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4759,1,3,0)
 ;;=3^Diabetes Type 2 w/ Skin Ulcer
 ;;^UTILITY(U,$J,358.3,4759,1,4,0)
 ;;=4^E11.622
 ;;^UTILITY(U,$J,358.3,4759,2)
 ;;=^5002657
 ;;^UTILITY(U,$J,358.3,4760,0)
 ;;=E11.628^^37^317^10
 ;;^UTILITY(U,$J,358.3,4760,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4760,1,3,0)
 ;;=3^Diabetes Type 2 w/ Skin Complications
 ;;^UTILITY(U,$J,358.3,4760,1,4,0)
 ;;=4^E11.628
 ;;^UTILITY(U,$J,358.3,4760,2)
 ;;=^5002658
 ;;^UTILITY(U,$J,358.3,4761,0)
 ;;=E11.630^^37^317^9
 ;;^UTILITY(U,$J,358.3,4761,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4761,1,3,0)
 ;;=3^Diabetes Type 2 w/ Periodontal Disease
 ;;^UTILITY(U,$J,358.3,4761,1,4,0)
 ;;=4^E11.630
 ;;^UTILITY(U,$J,358.3,4761,2)
 ;;=^5002659
 ;;^UTILITY(U,$J,358.3,4762,0)
 ;;=E11.638^^37^317^7
 ;;^UTILITY(U,$J,358.3,4762,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4762,1,3,0)
 ;;=3^Diabetes Type 2 w/ Oral Complications
 ;;^UTILITY(U,$J,358.3,4762,1,4,0)
 ;;=4^E11.638
 ;;^UTILITY(U,$J,358.3,4762,2)
 ;;=^5002660
 ;;^UTILITY(U,$J,358.3,4763,0)
 ;;=E11.649^^37^317^6
 ;;^UTILITY(U,$J,358.3,4763,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4763,1,3,0)
 ;;=3^Diabetes Type 2 w/ Hypoglycemia w/o Coma
 ;;^UTILITY(U,$J,358.3,4763,1,4,0)
 ;;=4^E11.649
 ;;^UTILITY(U,$J,358.3,4763,2)
 ;;=^5002662
 ;;^UTILITY(U,$J,358.3,4764,0)
 ;;=E11.69^^37^317^12
 ;;^UTILITY(U,$J,358.3,4764,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4764,1,3,0)
 ;;=3^Diabetes Type 2 w/ Spec Complications
 ;;^UTILITY(U,$J,358.3,4764,1,4,0)
 ;;=4^E11.69
 ;;^UTILITY(U,$J,358.3,4764,2)
 ;;=^5002664
 ;;^UTILITY(U,$J,358.3,4765,0)
 ;;=K85.9^^37^317^16
 ;;^UTILITY(U,$J,358.3,4765,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4765,1,3,0)
 ;;=3^Pancreatitis,Acute,Unspec
 ;;^UTILITY(U,$J,358.3,4765,1,4,0)
 ;;=4^K85.9
 ;;^UTILITY(U,$J,358.3,4765,2)
 ;;=^5008887
 ;;^UTILITY(U,$J,358.3,4766,0)
 ;;=R07.82^^37^317^15
 ;;^UTILITY(U,$J,358.3,4766,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4766,1,3,0)
 ;;=3^Intercostal Pain
 ;;^UTILITY(U,$J,358.3,4766,1,4,0)
 ;;=4^R07.82
 ;;^UTILITY(U,$J,358.3,4766,2)
 ;;=^5019199
 ;;^UTILITY(U,$J,358.3,4767,0)
 ;;=R07.89^^37^317^1
 ;;^UTILITY(U,$J,358.3,4767,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4767,1,3,0)
 ;;=3^Chest Pain,Other
 ;;^UTILITY(U,$J,358.3,4767,1,4,0)
 ;;=4^R07.89
 ;;^UTILITY(U,$J,358.3,4767,2)
 ;;=^5019200
 ;;^UTILITY(U,$J,358.3,4768,0)
 ;;=I95.9^^37^317^14
 ;;^UTILITY(U,$J,358.3,4768,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4768,1,3,0)
 ;;=3^Hypotension,Unspec
 ;;^UTILITY(U,$J,358.3,4768,1,4,0)
 ;;=4^I95.9
 ;;^UTILITY(U,$J,358.3,4768,2)
 ;;=^5008080
